Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
YKYY
(688658.SH)
Last Updated 00:00:00
News
Financials
Overview
Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit
Wallstreetcn
·
03/17/2026 10:28
SH
688336
-1.44%
SH
688513
-0.07%
HK
01877
+2.48%
Wallstreetcn
·
03/17/2026 10:28
SH
688336
-1.44%
SH
688513
-0.07%
HK
01877
+2.48%
Fangzhou, Youcare Partner To Advance AI In Chronic Disease Care
rttnews
·
03/01/2026 12:54
HK
06086
+0.99%
SH
510660
+0.22%
SH
512010
-0.57%
rttnews
·
03/01/2026 12:54
HK
06086
+0.99%
SH
510660
+0.22%
SH
512010
-0.57%
Fangzhou teams up with Youcare Pharma to improve chronic care services using AI, boosting digital transformation.
Unusual Whales
·
02/28/2026 15:22
SZ
159929
-0.71%
SH
512010
-0.57%
SH
688658
-4.14%
Unusual Whales
·
02/28/2026 15:22
SZ
159929
-0.71%
SH
512010
-0.57%
SH
688658
-4.14%
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services
GlobeNewswire
·
02/28/2026 15:12
SH
516610
-1.50%
SH
512010
-0.57%
SH
589720
+1.03%
GlobeNewswire
·
02/28/2026 15:12
SH
516610
-1.50%
SH
512010
-0.57%
SH
589720
+1.03%
YKYY: Planning to issue H shares and list on the Hong Kong Stock Exchange Limited
Wallstreetcn
·
12/05/2025 17:20
SH
688658
-4.14%
Wallstreetcn
·
12/05/2025 17:20
SH
688658
-4.14%
Guotai Haitong: siRNA drug technology upgrades drive breakthroughs in common disease treatment, Chinese companies can achieve differentiated advantages in multiple areas
Zhitong
·
10/10/2025 10:20
SH
600276
-1.24%
SH
601211
-1.03%
HK
02611
-1.35%
Zhitong
·
10/10/2025 10:20
SH
600276
-1.24%
SH
601211
-1.03%
HK
02611
-1.35%
Shenwan Hongyuan: Small nucleic acid drugs enter a rapid development stage, domestic companies accelerate to seize the blue ocean
Zhitong
·
09/26/2025 14:56
HK
01276
-0.73%
SH
688658
-4.14%
SH
600276
-1.24%
Zhitong
·
09/26/2025 14:56
HK
01276
-0.73%
SH
688658
-4.14%
SH
600276
-1.24%
Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines
Zhitong
·
09/25/2025 13:43
SH
688166
-2.38%
SZ
301096
+0.21%
SH
688658
-4.14%
Zhitong
·
09/25/2025 13:43
SH
688166
-2.38%
SZ
301096
+0.21%
SH
688658
-4.14%
YKYY's subsidiary YKYY013 injection has received FDA clinical trial approval
Zhitong
·
09/22/2025 17:20
SH
688658
-4.14%
Zhitong
·
09/22/2025 17:20
SH
688658
-4.14%
YKYY: Independent director Cheng Hua has applied for resignation due to personal reasons
Zhitong
·
09/11/2025 17:20
SH
688658
-4.14%
Zhitong
·
09/11/2025 17:20
SH
688658
-4.14%